Helius Medical Technologies, Inc. (HSDTW)

Market Cap	19.68M
Revenue (ttm)	295.00K
Net Income (ttm)	-21.29M
Shares Out	n/a
EPS (ttm)	-584.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	6,507
Open	0.0101
Previous Close	0.3680
Day's Range	0.0101 - 0.0101
52-Week Range	0.0006 - 0.5000
Beta	n/a
RSI	n/a
Earnings Date	Nov 14, 2025

About HSDTW

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. T...

• Industry: Electromedical and Electrotherapeutic Apparatus
• CEO: Dane Andreeff
• Employees: 21
• Stock Exchange: OTCMKTS
• Ticker Symbol: HSDTW